S&P ASX All Technology

US Dollar vs AUD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

KAPA Kairos Pharma Ltd

1.72

0.20 (13.16%)

05 Feb 2025 - Closed

Delayed by 15 minutes

Form S-1 - General form for registration of securities under the Securities Act of 1933

Article too big to display. Click here to view on the SEC website

Kairos Pharma (AMEX:KAPA)
Historical Stock Chart
From Jan 2025 to Feb 2025

Click Here for more Kairos Pharma Charts.

Kairos Pharma (AMEX:KAPA)
Historical Stock Chart
From Feb 2024 to Feb 2025

Click Here for more Kairos Pharma Charts.

Kairos Pharma Ltd News

Form PRE 14C - Other preliminary information statements
Wednesday 29 January 2025 (7 days ago) • Edgar (US Regulatory)

Form S-1 - General form for registration of securities under the Securities Act of 1933
Wednesday 29 January 2025 (7 days ago) • Edgar (US Regulatory)

Form D - Notice of Exempt Offering of Securities
Wednesday 29 January 2025 (1 week ago) • Edgar (US Regulatory)

Kairos Pharma to Present Short Talk on Its Investigational Compound KROS 101 at the 13th AACR-JCA Joint Conference February 5, 2024
Wednesday 29 January 2025 (1 week ago) • Business Wire

Kairos Pharma Provides Business Update and Outlook into 2025
Wednesday 22 January 2025 (2 weeks ago) • Business Wire

Form 8-K - Current report
Saturday 18 January 2025 (3 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 15 January 2025 (3 weeks ago) • Edgar (US Regulatory)

Kairos Pharma to Present at the Lytham Partners Investor Healthcare Summit
Wednesday 8 January 2025 (4 weeks ago) • Business Wire

Form 8-K - Current report
Saturday 14 December 2024 (2 months ago) • Edgar (US Regulatory)

Kairos Pharma Adds City of Hope Cancer Center for Phase 2 ENV105 Clinical Trial
Wednesday 4 December 2024 (2 months ago) • Business Wire

Form 8-K - Current report
Wednesday 20 November 2024 (3 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Friday 15 November 2024 (3 months ago) • Edgar (US Regulatory)

More Kairos Pharma Ltd News Articles

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions